戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tors associated with protection among adults at high risk.
2 ified some counties on major rivers as being at high risk.
3 e problems, half were at low risk, half were at high risk.
4  males were twice at likely as females to be at high risk.
5 es were at unclear risk, and 16 studies were at high risk.
6 ogic research of a broader range of patients at high-risk.
7 tive in preventing type 2 diabetes in people at high risk(1,2).
8              Some clinically normal patients at high risk (9 of 16) and at low risk (2 of 8) of devel
9 preventing thromboembolic events in patients at high risk and describes the emerging therapeutic stra
10 l enable the early identification of infants at high risk and facilitate novel strategies and interve
11 e eightfold difference in risk between women at high risk and those at general risk.
12 rediction of subsequent psychosis in persons at high risk and to determine the impact of adding the P
13 ic interventions, refining risk for families at high risk, and facilitating diagnosis and predicting
14   An observational cohort study of 405 women at high-risk, and 214 women at low-risk of sPTB.
15 icularly in regard to young children who are at high risk because of their continuing lung developmen
16 ve doses of macrocyclic GBCA with breast MRI at high-risk breast cancer screening exhibit T1 alterati
17 e, or who otherwise self-identified as being at high risk but were not in serodifferent partnerships
18 populations primordially, and in individuals at high risk by primary prevention.
19                          Health care workers at high risk can contribute in other ways to patients an
20        We estimated 6% (3-12) of males to be at high risk compared with 3% (2-7) of females.
21  we also estimated the number of individuals at high risk (defined as those that would require hospit
22  assay can be used individually for patients at high risk for a viral enteropathogen (e.g., in outbre
23  metabolite profiles might identify patients at high risk for ACLF and death.
24      Overweight children and adolescents are at high risk for adult and late life obesity.
25 monary angiography (CTPA) rates in subgroups at high risk for adverse imaging outcomes, including you
26 tin therapy alone in persons who have or are at high risk for ASCVD.
27 ied a subset of subjects from a birth cohort at high risk for asthma/allergy and determined the capac
28 er advance care planning to prevent patients at high risk for becoming unrepresented from meeting thi
29                         Identifying patients at high risk for being LTFU may help in choosing treatme
30 s have shown that when excluding individuals at high risk for bleeding, the net clinical benefit favo
31           Background Otherwise healthy women at high risk for breast cancer undergo annual contrast a
32 ses of gadoterate dimeglumine, healthy women at high risk for breast cancer who underwent annual cont
33 at NPS improves the identification of groups at high risk for breast cancer, type 2 diabetes, inflamm
34 otein profiling in plasma samples from women at high risk for breast cancer, which led us to focus on
35 sed mammography screening rates in survivors at high risk for breast cancer; however, this approach d
36 th EBV-1 and EBV-2 infection in a population at high risk for Burkitt lymphoma.
37 bstructive coronary artery disease (CAD) are at high risk for cardiovascular disease (CVD) events.
38                               Among patients at high risk for cardiovascular disease receiving maxima
39 n an independent cohort of 980 men and women at high risk for cardiovascular disease.
40 h HIV, especially in sub-Saharan Africa, are at high risk for cervical high-grade squamous intraepith
41 al records to identify hospitalized patients at high risk for clinical deterioration (which permits a
42                                     Patients at high risk for CMV based on pretransplant CMI develope
43 a personalized approach to managing patients at high risk for cognitive impairment after BMT.
44                           These patients are at high risk for colectomy, hospitalization, corticoster
45                   African Americans (AA) are at high risk for Colorectal Cancer (CRC).
46 argeted fluorescent peptide, in a population at high risk for colorectal cancer.
47 19 (Covid-19) and to protect persons who are at high risk for complications.
48 rth MAC score quartile) should be considered at high risk for CSA, warranting closer monitoring.
49 nded for antihypertensive medication who are at high risk for CV events.
50 ailure (HF) discharged from the hospital are at high risk for death and rehospitalization.
51  recommends that intensivists offer patients at high risk for death or severe functional impairment t
52 y ill, vitamin D-deficient patients who were at high risk for death.
53 rveillance or early detection tool for women at high risk for developing breast cancer.
54  There is potential benefit in screening men at high risk for developing breast cancer.
55 PTEN hamartoma tumor syndrome (PHTS) and are at high risk for developing breast, thyroid and other ca
56 RV) infection-particularly bronchiolitis-are at high risk for developing childhood asthma.
57 benefit cognitively normal patients that are at high risk for developing dementia.
58 iac biomarkers identify individuals with LVH at high risk for developing heart failure (HF).
59  diabetes who did not have diabetes but were at high risk for development of clinical disease.
60 binding monoclonal antibody to CD3 in people at high risk for disease.
61 stress in pregnant adolescents, a population at high risk for distress, in association with neonatal
62 edside "sitters" are often used for patients at high risk for falls, but they are expensive and their
63 y of systematic DES implantation in patients at high risk for FP restenosis.
64 ed in postmenopausal women with osteoporosis at high risk for fracture.
65 ute upper gastrointestinal bleeding who were at high risk for further bleeding or death, endoscopy pe
66 mproves outcomes in patients predicted to be at high risk for further bleeding or death, we randomly
67 rying and gun use during a crime in a sample at high risk for gun violence.
68 ing in a subset of patients determined to be at high risk for having a hereditary cancer syndrome, an
69 l guidelines recommend vaccination of adults at high risk for HBV infection, the prevalence of undete
70                  Patients with cirrhosis are at high risk for hepatocellular carcinoma (HCC) and ofte
71 pulation with haematological malignancies is at high risk for herpes zoster.
72 n and bisexual men, two key populations also at high risk for human immunodeficiency virus (HIV).
73 men and bisexual men, 2 key populations also at high risk for human immunodeficiency virus.
74                            Such patients are at high risk for hypoxic-ischemic brain injury, intracra
75 ts starting antiretroviral therapy (ART) are at high risk for immune reconstitution inflammatory synd
76 iciency virus (PLWH) with low CD4 counts are at high risk for immune reconstitution inflammatory synd
77  measures for the identification of children at high risk for impaired executive functions.
78 on is common and identifies patients with CS at high risk for in-hospital mortality.
79          The CXR-LC model identified smokers at high risk for incident lung cancer, beyond CMS eligib
80 esting to persons living in Iceland who were at high risk for infection (mainly those who were sympto
81 n-resistant Staphylococcus aureus (MRSA) are at high risk for infection after discharge.
82                 Kidney transplant recipients at high risk for infections might benefit from enhanced
83 piratory failure enable to identify patients at high risk for intubation.
84 ficiency virus (HIV)/HCV coinfection who are at high risk for liver disease progression.
85                                 Patients are at high risk for loss to follow-up by way of incarcerati
86  radiograph images may identify more smokers at high risk for lung cancer who could benefit from scre
87 omarkers may help identify patients with T1D at high risk for MACCE and CVD events very early in the
88 isease and history of heart failure (HF) are at high risk for major adverse cardiovascular events.
89                                  In patients at high risk for major adverse cardiovascular outcomes,
90 ergone lower-extremity revascularization are at high risk for major adverse limb and cardiovascular e
91            In matched full and half sibships at high risk for major depression, compared with individ
92 icting duties of a practicing surgeon who is at high risk for morbidity and mortality from Covid-19 i
93 s may aid physicians in identifying patients at high risk for Mp CAP.
94 ospitalization for HFpEF identifies patients at high risk for near-term clinical progression.
95 h (i.e., <= 32 weeks gestational age) remain at high risk for neurodevelopmental impairments.
96             The ability to identify patients at high risk for new-onset atrial fibrillation is limite
97 ic risk score, to identify those individuals at high risk for obesity.
98                                     Patients at high risk for POPF according to Fistula Risk Score (F
99 sk reduction of select pediatric populations at high risk for premature cardiovascular disease, inclu
100 n patients following successful resection or at high risk for progressing to PDA.
101           Methods of identifying BE patients at high risk for progression to high-grade dysplasia (HG
102 mise in enhancing risk prediction in persons at high risk for psychosis, although its potential utili
103        In conclusion, utilizing a population at high risk for PTB, we have identified a role for ADAM
104  Treatment of STEMI) pivotal study, subjects at high risk for recurrent ACS events (n = 907) were ran
105 ith aspirin or clopidogrel alone in patients at high risk for recurrent ischaemic stroke.
106 UIAs since growing aneurysms are known to be at high risk for rupture.
107                                      Persons at high risk for SARS-CoV-2 infection or its complicatio
108 ncology Group (COG) guidelines for survivors at high risk for second malignant neoplasms or cardiac d
109  for community-acquired pneumonia (CAP) were at high risk for severe outcomes.
110 drug delivery source, opioids leave patients at high risk for side effects after being dosed.
111  negative pressure wound therapy in patients at high risk for SSI.
112                               Among patients at high risk for stroke and increased risk of bleeding,
113                         Identifying patients at high risk for surgical recurrence may assist with med
114 ent 2 tools that identify household contacts at high risk for TB disease based on reportable informat
115 In this observational study of 77 spelunkers at high risk for TBRF, a single dose of 100 mg doxycycli
116 levated cardiac biomarkers in middle age are at high risk for the development of heart failure with p
117                                Patients were at high risk for thromboembolic or bleeding events (prio
118 mplications, as both PV and CEL patients are at high risk for thrombosis, and concomitant cytoreducti
119 (mean age, 49 years; age range, 28-75 years) at high risk for TOC who underwent transvaginal US withi
120 d low sensitivity for detecting TOC in women at high risk for TOC.
121 fication models able to identify individuals at high risk for transition from a diagnosis of depressi
122 B) HIV epidemics, identifying subpopulations at high risk for treatment failure and loss to care is c
123 s active bleeding at endoscopy (CP-B+AB) are at high risk for treatment failure, rebleeding, and mort
124 slows metabolic deterioration in individuals at high risk for type 1 diabetes.
125 ine after 1 year of treatment in individuals at high risk for type 1 diabetes.
126                                Among persons at high risk for type 2 diabetes not selected for vitami
127                       Medical inpatients are at high risk for VTE because of immobility as well as ac
128 oposed model identified very preterm infants at high-risk for cognitive, language, and motor deficits
129 llness that can be used to identify patients at high-risk for cognitive, mental health, and physical
130 staging system, but also identifies patients at high-risk for early death.
131     The identification of cirrhosis patients at high-risk for readmission is critical for developing
132 genomic approach for identifying individuals at high-risk for the inflammatory subtype of depression.
133  Plants adapted to extreme conditions can be at high risk from climate change; arctic-alpine plants,
134 emonstrates that surveillance of individuals at high-risk (HRIs) of developing pancreatic adenocarcin
135 ve a normal weight or who are overweight are at high risk if they have an excess of visceral adipose
136  as blood biomarkers to identify BE patients at high risk in the general population.
137 d be considered in patients determined to be at high risk, including first-degree relatives of patien
138 k of acquisition of HIV infection in persons at high risk is substantial.
139 l biomarkers to identify individuals who are at high risk is very much needed.
140 eration (CIMIC) programme, that was targeted at high-risk Medical Officer of Health (MOH) divisions i
141          The prison population is considered at high risk of acquiring infectious diseases due to con
142 g findings in cognitively normal individuals at high risk of AD.
143 identify patients with Fabry disease who are at high risk of adverse cardiac events.
144                                     They are at high risk of adverse outcomes in the first year of li
145                                     They are at high risk of adverse outcomes in the first year of li
146 on of more than six million people worldwide at high risk of Alzheimer's disease (AD) are those with
147 d biomarkers that may help to identify those at high risk of APNS and/or guide individual interventio
148 ited by an inability to identify individuals at high risk of APNS in the immediate aftermath of traum
149 ins alone in individuals with known ASCVD or at high risk of ASCVD.
150 tient groups not previously recognized to be at high risk of aspergillosis.
151 al of 806 pregnant women and their offspring at high risk of asthma or atopy, who were followed from
152  In a population of stable vascular patients at high risk of atherothrombotic events, the subset with
153            Forty-six percent of studies were at high risk of bias because of missing outcome data.
154                             All studies were at high risk of bias for index test domain because no re
155 ents) were included; seven were judged to be at high risk of bias.
156 ium after gadoxetic acid administration were at high risk of bias.
157 irin-naive participants <70 years of age not at high risk of bleeding (n=3540).
158  cardiovascular disease (ASCVD) risk but not at high risk of bleeding.
159  VTE, although caution is needed in patients at high risk of bleeding.
160  enrofloxacin or tulathromycin use in calves at high risk of bovine respiratory disease (BRD) on anti
161 lyamines and related metabolites in subjects at high risk of cardiovascular disease (CVD).
162 d into clinical care to identify individuals at high risk of CHD.
163                                        Those at high risk of CKD progression (eg, estimated GFR <30 m
164 r, often owing to adverse events, were found at high risk of clinical deterioration.
165 sed state, SOT recipients are presumed to be at high risk of complications with viral infections such
166 egnant women with metabolic risk factors are at high risk of complications.
167 ult in better monitoring of patients who are at high risk of conversion to exudative AMD.
168  to reduce residual inflammation in patients at high risk of coronary artery disease.
169 d laboratory data could identify individuals at high risk of COVID-19 and enable prioritization of PC
170  Patients with PH in the absence of eLAP are at high risk of death and in need of focused attention.
171 larly when heart involvement is present, are at high risk of death within a few months.
172 previously treated patients with CLL who are at high risk of death, and could be used in future prosp
173 ss of disease phase or treatment status, are at high risk of death.
174 megaly or with unfavorable tumor biology are at high risk of death.
175 HF with an implantable cardiac defibrillator at high risk of death.
176 emaining forests within such concessions are at high risk of deforestation, as there are normally no
177 e models can be used to identify individuals at high risk of dementia in the population and are able
178       We sought to determine whether infants at high risk of developing a food allergy benefited from
179 hat efficiently identify individuals who are at high risk of developing accelerated vascular damage,
180 ults support the hypothesis that individuals at high risk of developing AML might benefit from target
181                                       Calves at high risk of developing BRD were randomly enrolled in
182  Patients with rheumatoid arthritis (RA) are at high risk of developing cardiovascular disease (CVD).
183  Rationale: Identification of younger adults at high risk of developing chronic obstructive pulmonary
184 cific CMI identifies D+/R+ kidney recipients at high risk of developing CMV infection if not receivin
185 tive performance and to identify individuals at high risk of developing cognitive impairment.
186 ndividuals with cryptococcal antigenemia are at high risk of developing cryptococcal meningitis if un
187  term infants (at least 37 weeks' gestation) at high risk of developing eczema (ie, at least one firs
188 al function in patients with type 2 diabetes at high risk of developing end-stage kidney disease.
189 f food allergy in specific groups of infants at high risk of developing food allergy: those sensitize
190 ed medical records of HCC patients and those at high risk of developing HCC through cross-sectional s
191 ronary interventions (PCIs), patients remain at high risk of developing late cardiovascular events.
192 reventive approaches for individuals who are at high risk of developing lung cancer.
193 of-of-concept model for identifying subjects at high risk of developing PD by analysis of cardiac ele
194              Organ transplant recipients are at high risk of developing skin cancer.
195 neficial to preoperatively identify patients at high risk of developing SSI.
196 alth-care policies advocate that individuals at high risk of developing T2DM undertake lifestyle modi
197 lts recently diagnosed with T2D (n = 795) or at high risk of developing the disease (n = 2,234).
198 registers can be used to predict individuals at high risk of developing type 2 diabetes (T2D) comorbi
199 ll related cytokines, distinguishes patients at high risk of disease activity and severe cortical dam
200 gy Group performance status of 0-2, and were at high risk of disease as defined by the presence of an
201  help in the prediction of those individuals at high risk of disease in the general population.
202 , there is a lack of tools to identify those at high risk of early mortality who may benefit from adj
203                           Identifying people at high risk of experiencing these complications is impo
204 Female, obese and malnourished patients were at high risk of extracellular fluid accumulation.
205 pril 2017 to January 2018 among 641 patients at high risk of extubation failure (ie, older than 65 ye
206          In mechanically ventilated patients at high risk of extubation failure, the use of high-flow
207                               In individuals at high risk of fracture, the benefit versus risk profil
208                                  Individuals at high risk of fractures do not receive adequate treatm
209                           These patients are at high risk of future vascular events.
210                    Children scoring >=3 were at high risk of having asthma at school-age (PPV > 75%;
211 g applied to ECGs may help identify subjects at high risk of having prodromal PD.
212 entially assist in the selection of patients at high risk of having varices and prioritize them for e
213 ta show that only about 24%-45% of US adults at high risk of HBV infection are protected.
214  pulmonary hypertension) identified patients at high risk of HF readmission.
215  models using EHR data can identify patients at high risk of HIV acquisition who could benefit from P
216 very early treatment of HIV-exposed neonates at high risk of HIV acquisition.
217 within 48 h of birth in HIV-exposed neonates at high risk of HIV acquisition.
218 reasing the risk of HIV infection in persons at high risk of HIV acquisition.
219  effective antiretroviral therapy to persons at high risk of HIV acquisition.
220 of risk assessment tools to identify persons at high risk of HIV acquisition; the rates of adherence
221 profiles in an observational cohort of women at high risk of HIV infection (CAPRISA 004, n = 779) and
222 ond, there should be no more than one period at high risk of HIV infection during the follow-up perio
223  with human immunodeficiency virus (HIV) are at high risk of human papillomavirus (HPV)-associated ca
224 c) values of 5.8-10.0% (40-86 mmol/mol), and at high risk of hypoglycaemia (recent severe hypoglycaem
225 ultidrug-resistant tuberculosis (MDR-TB) are at high risk of infection and subsequent disease.
226 atients with haematological malignancies are at high risk of infection because of various mechanisms
227                             Pastoralists are at high risk of infection but data on brucellosis from t
228 o-B-type natriuretic peptide (NT-proBNP) are at high risk of infection is unknown.
229 ersons with chronic kidney disease (CKD) are at high risk of infection.
230 rticularly those with previous stenting, are at high risk of ischaemic events.
231                                      Persons at high risk of latent tuberculosis infection (LTBI) and
232 young adults with acute myeloid leukemia are at high risk of life-threatening invasive fungal disease
233  findings to improve case finding for people at high risk of liver disease will allow for effective m
234 le analysis identified a profile of children at high risk of liver injury (odds ratio, 1.56; 95% conf
235 time of the CM episode may identify children at high risk of long-term neurocognitive impairment.
236 isk of DR, and radiotherapy for LPS subtypes at high risk of LR when treated with surgery alone.
237 risk scores (PRS) to identify subpopulations at high risk of lung cancer for prevention.
238 tively used in discriminating subpopulations at high risk of lung cancer, who might benefit from a pr
239 type 2 diabetes mellitus and previous MI are at high risk of MACE and cardiovascular death/hospitaliz
240  coronavirus disease (COVID-19) pandemic are at high risk of mental morbidity.Objectives: To assess t
241                        Piscivorous birds are at high risk of mercury exposure in aquatic food webs, a
242 atitis C virus (HCV)-coinfected patients are at high risk of metabolic complications and liver-relate
243 al signs to identify children with pneumonia at high risk of mortality in the outpatient setting in h
244  and preserved ejection fraction (HFpEF) are at high risk of mortality, hospitalizations, and reduced
245 k score can help to identify school children at high risk of myopia.
246 could potentially be used to stratify people at high risk of NKTCL for targeted prevention.
247 d seek to identify the subset of T1b cancers at high risk of nodal metastasis and thus would benefit
248 d VD supplementation trial in pregnant women at high risk of offspring asthma (N = 806 mother-offspri
249 tle information about vulnerable populations at high risk of opioid abuse and death.
250 appropriate care and maintenance of patients at high risk of peri-implant diseases.
251  should be used to select a study population at high risk of phenoconversion, to enable more rapid cl
252  support will be key in reaching populations at high risk of presenting with advanced HIV.
253 uberculosis, children aged under 5 years are at high risk of progressing first to tuberculosis infect
254 on of children with sub-clinical disease and at high risk of progression to clinically overt disease,
255  progression that could distinguish patients at high risk of progression to MM and, thus, improve on
256 story of prior autoimmune ocular disease are at high risk of recurrence of ocular complications.
257 ntermediate risk of recurrence, and 47% were at high risk of recurrence.
258  used in 52 kidney transplants, including 39 at high risk of recurrence.
259 a prediction algorithm may identify patients at high risk of recurrent SARS-CoV-2 positivity and help
260 dence, previously treated individuals remain at high risk of recurrent tuberculosis and contribute su
261 blish optimal treatment duration in patients at high risk of recurrent VTE.
262 re aged 50 years or younger, were considered at high risk of regimen-related toxicity associated with
263 h rhabdomyosarcoma who were considered to be at high risk of relapse: those with non-metastatic incom
264         Patients infected with influenza are at high risk of secondary bacterial infection, which is
265 ople (4% [3-9] of the global population) are at high risk of severe COVID-19 and would require hospit
266               Determining which patients are at high risk of severe illness or mortality is essential
267 nfection in the immunocompromised population at high risk of severe strongyloidiasis syndromes.
268 ng all nine provinces as well as populations at high risk of soil-transmitted helminth infections liv
269  groups of patients with atrial fibrillation at high risk of stroke and bleeding who have been under-
270 lusion, in patients with atrial fibrillation at high risk of stroke and bleeding.
271 actic neuroprotective therapy in populations at high risk of stroke.SIGNIFICANCE STATEMENT With recen
272  used to identify suicide attempters who are at high risk of subsequent suicide death.
273 atients attending hospital for self-harm are at high risk of suicide, especially immediately after ho
274 liated hospitals and nursing assistants were at high risk of symptoms of anxiety and peritraumatic di
275  of HHCs in these high-burden countries were at high risk of TB disease and infection, yet few were r
276                 13 805 non-U.S.-born persons at high risk of TB infection or progression to TB diseas
277     People with advanced HIV (CD4<50) remain at high risk of TB or death despite the initiation of an
278 munodeficiency virus (HIV) (CD4 < 50) remain at high risk of tuberculosis (TB) or death despite the i
279 utcomes and maybe most warrated for patients at high risk of VAN-failure or VAN-associated toxicity.
280 ents treated with immunomodulatory drugs are at high risk of venous thromboembolism (VTE), but data a
281                                  In patients at high risk of VRE infection, high abundance of the lan
282 phylactic treatment strategies of landscapes at high risk of wildfires through prolonged prevention o
283 of Myocardial Infarction identified patients at high-risk of cardiovascular and noncardiovascular eve
284 ple with diabetes and chronic kidney disease at high-risk of early mortality is a priority to guide i
285 e generated PRS in predicting subpopulations at high-risk of lung cancer in an independent prospectiv
286 s should allow identification of individuals at high-risk of progression, permitting targeted therapy
287      Essential Thrombocythemia (ET) patients at high-risk of thrombosis require cytoreductive treatme
288 redictors of closures indicating populations at "high risk" of closure (patient characteristics, faci
289 ation make it difficult to identify persons "at high risk" of AD in the preclinical stages.
290 of patients who had been identified as being at high risk; results of this monitoring were then commu
291                        In Alabama, screening at high-risk settings identified significant hepatitis C
292 ing disease progression, recognizing lesions at high risk, simulating treatments, and ultimately opti
293  the author, and other health care providers at high risk, the option to opt out of the care Covid-19
294 en, suggesting that young children are still at high risk to the newly emerged A(H3N2)v viruses.
295                 Incarcerated populations are at high-risk to develop tuberculosis (TB), however their
296  included across three study groups: infants at high risk who developed ASD (N=71), infants at high r
297 ctories from 6 to 24 months only for infants at high risk who developed ASD.
298  high risk who developed ASD (N=71), infants at high risk who did not develop ASD (N=234), and infant
299 f concentration >60 ng/l identified patients at high risk with a positive predictive value (PPV) of 7
300                                  Among those at high risk (with a Diabetes Prevention Trial-Type 1 Ri

 
Page Top